Literature DB >> 23316684

Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.

Christine J O'Neill1, Nicholas Coorough, James C Lee, Joshua Clements, Leigh W Delbridge, Rebecca Sippel, Mark S Sywak, Herb Chen, Stan B Sidhu.   

Abstract

BACKGROUND: The prognostic influence of lateral neck nodal metastases present at the time of diagnosis of papillary thyroid cancer (PTC) remains controversial. This study aims to document disease outcomes and nodal recurrence rates in such patients.
METHODS: Patients with PTC and lateral neck nodal metastases who underwent concurrent total thyroidectomy, central and lateral compartment neck dissection between 2000 and 2010 were identified from the prospectively maintained surgical databases of The University of Sydney and University of Wisconsin Endocrine Surgical Units. Disease outcomes and nodal recurrence rates were compared at 12 months post-operatively and in longer-term follow-up.
RESULTS: During this 11-year period, 121 patients were identified. Mean age was 45 years; 58% were female and 98% underwent post-operative radioactive iodine ablation. At a median follow-up of 31 months (range 12-140), there were no disease-specific deaths and disease-free survival (defined by stimulated serum thyroglobulin (Tg) < 2.0 μg/L, negative clinical and radiological examination) was 66%. Of the 50 patients with persistently elevated Tg measured 12 months post-operatively, 15 developed clinical lateral neck nodal recurrence. All have undergone re-operative surgery. Elevated stimulated Tg at 12 months post-operatively and a nodal ratio of >30% were significantly associated with an increased risk of lateral neck nodal recurrence.
CONCLUSION: With total thyroidectomy, formal compartmental neck dissection and radioactive iodine treatment, disease-free survival can be achieved in the majority of patients with PTC and synchronous lateral neck nodal metastases. A persistently elevated Tg post-operatively and a high ratio of metastatic nodes identify patients at increased risk of locoregional recurrence.
© 2013 The Authors. ANZ Journal of Surgery © 2013 Royal Australasian College of Surgeons.

Entities:  

Keywords:  carcinoma; local; neoplasm recurrence; papillary; thyroid neoplasm

Mesh:

Substances:

Year:  2013        PMID: 23316684     DOI: 10.1111/ans.12045

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  5 in total

1.  Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden.

Authors:  Sarah C Oltmann; Glen Leverson; Suzy Hsiu-I Lin; David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2013-12-18       Impact factor: 2.192

Review 2.  The Role of Node Dissection for Thyroid Cancer.

Authors:  Reese W Randle; Susan C Pitt
Journal:  Adv Surg       Date:  2021-07-06

3.  Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection.

Authors:  Carlos Gustavo Rivera-Robledo; David Velázquez-Fernández; Juan Pablo Pantoja; Mauricio Sierra; Bernardo Pérez-Enriquez; Raul Rivera-Moscoso; Mónica Chapa; Miguel F Herrera
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

4.  Pattern of neck recurrence after lateral neck dissection for cervical metastases in papillary thyroid cancer.

Authors:  William F McNamara; Laura Y Wang; Frank L Palmer; Iain J Nixon; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Surgery       Date:  2016-03-16       Impact factor: 3.982

5.  Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity.

Authors:  Jae Won Chang; Sung Un Kang; Yoo Seob Shin; Kang Il Kim; Seong Jin Seo; Sang Sik Yang; Jong-Soo Lee; Eunpyo Moon; Keunho Lee; Chul-Ho Kim
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.